What is NDC 17312-019?
The NDC code 17312-019 is assigned by the FDA to the product Irritable Bowel Syndrome Therapy which is a human over the counter drug product labeled by Trp Company. The generic name of Irritable Bowel Syndrome Therapy is asafetida - bismuth subnitrate - bryonia alba root - activated charcoal - lycopodium clavatum spore - sodium carbonate - strychnos nux-vomica seed - veratrum album root -. The product's dosage form is tablet, orally disintegrating and is administered via oral form. The product is distributed in a single package with assigned NDC code 17312-019-14 1 bottle in 1 package / 70 tablet, orally disintegrating in 1 bottle. This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information, RxNorm crosswalk and the complete product label.
What are the uses for Irritable Bowel Syndrome Therapy?
|Color(s)||WHITE (C48325) |
|Shape||DIAMOND (C48338) |
|Size(s)||13 MM |
NDC Code 17312-019-14
Package Description: 1 BOTTLE in 1 PACKAGE / 70 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE
Irritable Bowel Syndrome Therapy Product Label
FDA filings in the form of structured product labels are documents that include all published material associated whith this product. Product label information includes data like indications and usage generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.
* Please review the disclaimer below.